Comment from Juul Labs Inc.

Summary: Juul Labs, Inc. supports the proposed guidance but urges the FDA to adopt a framework that prioritizes the authorization of flavored ENDS to combat the illicit market. They argue that the FDA should incorporate "reach" (the proportion of smokers who adopt a product) into its public health impact analysis and streamline the PMTA review process to provide more authorized options for adult smokers.